| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.26 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |